Boston Scientific Corporation

World Rank (Jan-05-2024)

171

Market Cap (Jan-05-2024)

85.218 Billion USD

World Rank (Jul-30-2023)

200

Market Cap (Jul-30-2023)

74.315 Billion USD

World Rank (Jan-07-2022)

301

Market Cap (Jan-07-2022)

60.006 Billion USD

World Rank (Jan-01-2021)

315

Market Cap (Jan-01-2021)

50.913 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 109

Headquarters Country

USA

Nasdaq / NYSE Code

BSX

Market Cap (Mar-08-2026)

105.88

CEO

Michael F. Mahoney

Founders

Peter Nicholas

John Abele

Employee Count

51,000

Employee Count as of Date

As on 2022

Headquarters City/State

Massachusetts

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

14,240 Million USD

Annual Operating Income in USD

2,417 Million USD

Annual Net Income in USD

1,570 Million USD

Annual Results for Period Ending

Dec-2023 ending year

Total Assets in USD

35,136 Million USD

Total Liabilities in USD

15,606 Million USD

Total Equity in USD

19,530 Million USD

Balance Sheet for Period Ending

Dec-2023 ending year

Business Sector

Healthcare

Medical Equipment / Instruments

HealthCare Products

Company Website

BOSTON SCIENTIFIC CORPORATION

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

BOSTON SCIENTIFIC CORPORATION is Medical Device manufacturing company with headquarters is in USA. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

BOSTON SCIENTIFIC CORPORATION have 25,000 employees in 40 countries across six continents are committed to doing business sustainably and responsibly in the communities where they live and work.

As on 2022, BOSTON SCIENTIFIC CORPORATION has 51,000 employees.

BOSTON SCIENTIFIC CORPORATION annual revenue generated for period ending Dec-2022 was 12,682 million USD.

BOSTON SCIENTIFIC CORPORATION annual net income generated for period ending Dec-2022 was 642 million USD.

Explore BOSTON SCIENTIFIC CORPORATION Businesses

Endoscopy
Cardiology
Nuromodulation
Peripheral Interventions
Rhythem Management
Urology and Pelvic Health

Facts About Company

BOSTON SCIENTIFIC CORPORATION annual revenue generated for period ending Dec-2021 was 11,888 million USD.

BOSTON SCIENTIFIC CORPORATION annual net income generated for period ending Dec-2021 was 985 million USD.

Total Assets as on Dec-2021 was 32,229 Million USD.

Total Liabilities as on Dec-2021 was 15,607 Million USD.

Total Equity as on Dec-2021 was 16,622 Million USD.

Annual Results Summary

BOSTON SCIENTIFIC CORPORATION - Annual Results - Revenue and Net Income - in Million USD:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2023	14,240	2,417	1,570
Dec-2022	12,682	2,033	642
Dec-2021	11,888	1,824	985
Dec-2020	9,913	684	-173
Dec-2019	10,735	1,740	4,700
Dec-2018	9,823	1,659	1,671
Dec-2017	9,048	1,531	104
Dec-2016	8,386		347

Balance Sheet Summary

BOSTON SCIENTIFIC CORPORATION - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2023	35,136	15,606	19,530
Dec-2022	32,469	14,896	17,573
Dec-2021	32,229	15,607	16,622
Dec-2020	30,777	15,450	15,326
Dec-2019	30,565	16,688	13,877
Dec-2018	20,999	12,273	8,726
Dec-2017	19,042	12,030	7,012

Founded Year

1979

Institutional Investors

Top 30 Institutional Holder Names in BOSTON SCIENTIFIC CORPORATION as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	BLACKROCK INC.	09/30/2023	12,93,07,129	-81,86,920	-5.95%	$6,963,189
2	FMR LLC	09/30/2023	12,59,20,357	80,45,263	6.83%	$6,780,811
3	VANGUARD GROUP INC	09/30/2023	12,37,68,348	15,25,432	1.25%	$6,664,926
4	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	09/30/2023	6,25,33,382	-66,03,703	-9.55%	$3,367,423
5	STATE STREET CORP	09/30/2023	6,19,45,856	-12,46,041	-1.97%	$3,335,784
6	WELLINGTON MANAGEMENT GROUP LLP	09/30/2023	4,20,76,529	23,36,348	5.88%	$2,265,821
7	PRIMECAP MANAGEMENT CO/CA/	09/30/2023	3,73,55,169	-73,810	-0.20%	$2,011,576
8	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	2,69,96,317	9,48,203	3.64%	$1,453,752
9	BANK OF AMERICA CORP /DE/	09/30/2023	2,52,91,179	-12,95,000	-4.87%	$1,361,930
10	JPMORGAN CHASE & CO	09/30/2023	2,41,03,972	9,40,531	4.06%	$1,297,999
11	BOLLARD GROUP LLC	09/30/2023	2,33,44,726	-3,30,355	-1.40%	$1,257,113
12	DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT	09/30/2023	2,22,98,154	8,06,030	3.75%	$1,200,756
13	MORGAN STANLEY	09/30/2023	2,12,00,339	4,81,891	2.33%	$1,141,638
14	CITADEL ADVISORS LLC	09/30/2023	2,11,56,222	56,99,874	36.88%	$1,139,263
15	JANUS HENDERSON GROUP PLC	09/30/2023	2,05,57,658	6,88,373	3.47%	$1,107,030
16	ARTISAN PARTNERS LIMITED PARTNERSHIP	09/30/2023	1,78,09,043	-12,20,453	-6.41%	$959,017
17	BANK OF NEW YORK MELLON CORP	09/30/2023	1,72,07,345	51,293	0.30%	$926,616
18	GOLDMAN SACHS GROUP INC	09/30/2023	1,66,18,338	-21,52,877	-11.47%	$894,898
19	INVESCO LTD.	09/30/2023	1,48,62,018	2,11,732	1.45%	$800,320
20	AMUNDI	09/30/2023	1,48,03,910	-18,85,154	-11.30%	$797,191
21	NORTHERN TRUST CORP	09/30/2023	1,38,90,530	5,31,914	3.98%	$748,005
22	NORGES BANK	12/31/2022	1,36,70,207	3,44,285	2.58%	$736,141
23	LEGAL & GENERAL GROUP PLC	09/30/2023	1,12,53,368	-2,51,576	-2.19%	$605,994
24	MILLENNIUM MANAGEMENT LLC	09/30/2023	1,11,36,194	9,16,118	8.96%	$599,684
25	VONTOBEL ASSET MANAGEMENT INC	09/30/2023	99,59,429	-9,685	-0.10%	$536,315
26	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	95,62,454	2,08,515	2.23%	$514,938
27	LAZARD ASSET MANAGEMENT LLC	09/30/2023	89,07,137	-2,85,441	-3.11%	$479,649
28	VOYA INVESTMENT MANAGEMENT LLC	09/30/2023	84,19,859	-12,13,719	-12.60%	$453,409
29	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	76,78,013	4,41,622	6.10%	$413,461
30	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	76,42,834	2,01,008	2.70%	$411,567